PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma

BACKGROUND: Molecular biomarkers assisting risk-group assignment and subsequent treatment stratification are urgently needed for patients with squamous cell cancer of the head and neck region (HNSCC). Aberrant methylation is a frequent event in cancer and, therefore, a promising source for potential...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Epigenetics
Autors principals: Sailer, Verena, Holmes, Emily Eva, Gevensleben, Heidrun, Goltz, Diane, Dröge, Freya, Franzen, Alina, Dietrich, Jörn, Kristiansen, Glen, Bootz, Friedrich, Schröck, Andreas, Dietrich, Dimo
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5290668/
https://ncbi.nlm.nih.gov/pubmed/28174607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-017-0317-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars